Comparisons

Chasteberry or Red Clover?

Chasteberry (Vitex agnus-castus) and red clover (Trifolium pratense) are sold for hormone-related complaints, but they target different life stages and their evidence is limited. The table is built from the sourced cards of both herbs.

Chasteberry or Red Clover?
AspectChasteberry SeedVitex agnus-castusRed CloverTrifolium pratense
Strongest evidenceB Limited clinical evidenceB Limited clinical evidence
NeedsWomen’s HealthWomen’s Health, Heart & Circulation
FormSeedDried Herb & Tea
How to useAdult women use a ready-made product with standardised dry extract as labelled (e.g. 20 mg dry extract once daily).Studies used standardised isoflavone extracts, which were used for up to 2 years with apparent safety. There is no verified dose for tea.
PregnancyAvoidAvoid
BreastfeedingAvoidAvoid
Recommended minimum ageFrom age 18Not stated
Drug interactionsInteractions reportedInteractions reported
Duration limit3 months for effect; see a doctor if symptoms persist after 3 monthsNot stated

Which one, when?

Chasteberry Seed

Its standardised dry extract may support premenstrual syndrome (PMS) symptoms; studies are mostly positive but at high risk of bias. Use regularly for 3 months; not recommended under 18.

Full card →

Red Clover

Its isoflavone extracts have given inconsistent results for menopausal hot flushes; a possible drop in total cholesterol has been reported in menopausal women. There is no confirmed dose for the tea.

Full card →

Good to know

  • People with a history of hormone-sensitive cancer should talk to a doctor before chasteberry and should not use red clover.
  • Red clover may raise bleeding risk; do not use it with blood thinners or before surgery.
  • Neither is recommended during pregnancy or breastfeeding.

Sources

  1. European Union herbal monograph on Vitex agnus-castus L., fructus – Revision 1EMA HMPC · 2018 · MonographSource accessed:
  2. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysisAmerican Journal of Obstetrics and Gynecology · 2017 · Systematic reviewSource accessed:
  3. Red Clover: Usefulness and SafetyNIH NCCIH · 2025 · Official agency informationSource accessed:
  4. Red CloverMemorial Sloan Kettering Cancer Center — About Herbs · 2022 · Reference bookSource accessed: